| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Quoin Pharmaceuticals, Ltd. | Chief Financial Officer | Ordinary Shares | 151,077 | $67,985 | $0.4500 | 23 Dec 2024 | Direct |
| Quoin Pharmaceuticals, Ltd. | Chief Financial Officer | Share Option (Right to Buy) | 338,994 | 09 Dec 2024 | Direct | ||
| Quoin Pharmaceuticals, Ltd. | Chief Financial Officer | Series F Warrants (right to buy) | 122,221 | 23 Dec 2024 | Direct | ||
| Quoin Pharmaceuticals, Ltd. | Chief Financial Officer | Series G Warrants (right to buy) | 122,221 | 23 Dec 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| QNRX | Quoin Pharmaceuticals, Ltd. | 23 Dec 2024 | 3 | +$54,999 | 4 | Chief Financial Officer | 27 Dec 2024, 17:16 |
| QNRX | Quoin Pharmaceuticals, Ltd. | 09 Dec 2024 | 1 | $0 | 4 | Chief Financial Officer | 10 Dec 2024, 16:51 |
| QNRX | Quoin Pharmaceuticals, Ltd. | 09 Sep 2024 | 5 | +$23,205 | 4 | Chief Financial Officer | 11 Sep 2024, 16:30 |
| QNRX | Quoin Pharmaceuticals, Ltd. | 26 Oct 2023 | 1 | $0 | 4 | Chief Financial Officer | 30 Oct 2023, 16:12 |
| QNRX | Quoin Pharmaceuticals, Ltd. | 01 Jan 2023 | 0 | $0 | 3 | Chief Financial Officer | 03 Jan 2023, 08:40 |